ey0018.4-5 | Growth Hormone Therapy: Safety | ESPEYB18
L Savendahl , M Polak , P Backeljauw , JC Blair , BS Miller , TR Rohrer , A Hokken-Koelega , A Pietropoli , N Kelepouris , J Ross
ey0018.7-3 | Clinical Guidance | ESPEYB18
KO Klein , A Freire , MG Gryngarten , GB Kletter , M Benson , BS Miller , TS Dajani , EA Eugster , N Mauras
ey0018.9-7 | Surveillance strategies of endocrine complications | ESPEYB18
A Cattoni , F Parissone , I Porcari , S Molinari , N Masera , M Franchi , S Cesaro , R Gaudino , P Passoni , A. alessandro.cattoni@unimib.it Balduzzi
ey0018.10-3 | (1) | ESPEYB18
G d'Annunzio , C Maffeis , V Cherubini , I Rabbone , A Scaramuzza , R Schiaffini , N Minuto , G Piccolo , M Maghnie
ey0019.3-5 | Follow-up paper from the 2021 Yearbook | ESPEYB19
T Mosaferi , K Tsai , S Sovich , H Wilhalme , N Kathuria-Prakash , SS Praw , A Drakaki , TE Angell , MG Lechner
ey0019.3-8 | Congenital hypothyroidism | ESPEYB19
A Marr , N Yokubynas , K Tang , D Saleh , DK Wherrett , R Stein , E Bassilious , P Chakraborty , SE Lawrence
ey0019.8-11 | New Concerns | ESPEYB19
Z Zajkowska , N Gullett , A Walsh , V Zonca , GA Pedersen , L Souza , C Kieling , HL Fisher , BA Kohrt , V Mondelli
ey0019.11-10 | New predictors of obesity development | ESPEYB19
Co Buck , N Li , CB Eaton , KT Kelsey , KM Cecil , HJ Kalkwarf , K Yolton , BP Lanphear , A Chen , JM Braun
ey0019.14-19 | Reviews | ESPEYB19
Miller Karl N , Victorelli Stella G , Salmonowicz Hanna , Dasgupta Nirmalya , Liu Tianhui , Passos Joao F , Adams Peter D
ey0019.15-8 | Assorted Conditions | ESPEYB19
Henriksen L Scheutz , Petersen J Holm , NE Skakkebaek , N Jorgensen , HE Virtanen , L Priskorn , A Juul , J Toppari , KM Main